DK0467564T3 - Behandling af inflammatoriske sygdomme med 15-ketoprostaglandinforbindelser - Google Patents

Behandling af inflammatoriske sygdomme med 15-ketoprostaglandinforbindelser

Info

Publication number
DK0467564T3
DK0467564T3 DK91306069.5T DK91306069T DK0467564T3 DK 0467564 T3 DK0467564 T3 DK 0467564T3 DK 91306069 T DK91306069 T DK 91306069T DK 0467564 T3 DK0467564 T3 DK 0467564T3
Authority
DK
Denmark
Prior art keywords
treatment
inflammatory diseases
ketoprostaglandin
compounds
ketoprostaglandin compounds
Prior art date
Application number
DK91306069.5T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DK0467564T3 publication Critical patent/DK0467564T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91306069.5T 1990-07-10 1991-07-03 Behandling af inflammatoriske sygdomme med 15-ketoprostaglandinforbindelser DK0467564T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18496390 1990-07-10

Publications (1)

Publication Number Publication Date
DK0467564T3 true DK0467564T3 (da) 1996-05-13

Family

ID=16162415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91306069.5T DK0467564T3 (da) 1990-07-10 1991-07-03 Behandling af inflammatoriske sygdomme med 15-ketoprostaglandinforbindelser

Country Status (10)

Country Link
US (1) US5346921A (fr)
EP (1) EP0467564B1 (fr)
JP (1) JP2562239B2 (fr)
KR (1) KR100195430B1 (fr)
AT (1) ATE137116T1 (fr)
CA (1) CA2046069C (fr)
DE (1) DE69118978T2 (fr)
DK (1) DK0467564T3 (fr)
ES (1) ES2089136T3 (fr)
GR (1) GR3019760T3 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508302A (en) * 1994-09-28 1996-04-16 American Home Products Corporation Phospholipase A2 inhibitors
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
US6242485B1 (en) * 1996-06-10 2001-06-05 R-Tech Ueno Endothelin antagonist
EP0978284B1 (fr) 1997-11-28 2008-07-23 Sucampo AG Utilisation de composés de type 15-keto-prostaglandine-e en tant qu'antagoniste de l'endotheline
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
DE60039727D1 (de) 1999-10-15 2008-09-11 Sucampo Ag Neue Zusammensetzung enthaltend eine bicyclische Verbindung und ein Glycerid
AR035242A1 (es) * 2001-05-18 2004-05-05 Sucampo Ag Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado
WO2003018025A1 (fr) * 2001-08-23 2003-03-06 Sucampo Ag Procede et composition pour le traitement de l'hypertension oculaire et du glaucome
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US8143316B2 (en) * 2005-03-04 2012-03-27 Sucampo Ag Method for treating peripheral vascular diseases
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
WO2012176792A1 (fr) * 2011-06-21 2012-12-27 株式会社アールテック・ウエノ Composition pharmaceutique pour des maladies inflammatoires, maladies allergiques et maladies auto-immunes
KR102578588B1 (ko) * 2021-07-22 2023-09-14 정찬희 자석이 구비된 도어 잠금장치

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2321876A1 (fr) * 1975-08-29 1977-03-25 Roussel Uclaf Nouveaux derives cyclopentaniques, leur procede de preparation et leur application comme medicaments
US4097603A (en) * 1977-09-06 1978-06-27 The Upjohn Company Gastric cytoprotection with non-antisecretory doses of prostaglandins
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
JPS59134746A (ja) * 1982-11-05 1984-08-02 ザ，プロクタ−，エンド，ギヤンブル，カンパニ− 新規プロスタグランジン類似体
EP0153858A3 (fr) * 1984-02-29 1985-12-11 The Upjohn Company Application thérapeutique de prostaglandines
US4612330A (en) * 1985-02-04 1986-09-16 Eli Lilly And Company Antiinflammatory method
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
CA1323364C (fr) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandines e et agents anti-ulcereux contenant celles-ci
CA1322749C (fr) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandines de la serie d, et tranquilisants et soporifiques en contenant
CA1324129C (fr) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandines de la serie f
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
ATE78465T1 (de) * 1987-10-02 1992-08-15 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.
JP2515442B2 (ja) * 1990-05-01 1996-07-10 株式会社上野製薬応用研究所 膵臓疾患処置剤

Also Published As

Publication number Publication date
JPH0532551A (ja) 1993-02-09
CA2046069A1 (fr) 1992-01-11
ATE137116T1 (de) 1996-05-15
DE69118978T2 (de) 1996-11-14
EP0467564B1 (fr) 1996-04-24
ES2089136T3 (es) 1996-10-01
KR100195430B1 (ko) 1999-06-15
GR3019760T3 (en) 1996-07-31
US5346921A (en) 1994-09-13
EP0467564A3 (en) 1992-07-08
KR920002151A (ko) 1992-02-28
CA2046069C (fr) 2002-04-09
JP2562239B2 (ja) 1996-12-11
DE69118978D1 (de) 1996-05-30
EP0467564A2 (fr) 1992-01-22

Similar Documents

Publication Publication Date Title
DK0453127T3 (da) Behandling af katarakt med 15-keto-prostaglandinforbindelser
ES2093361T3 (es) Tratamiento de enfermedades neurodegenerativas.
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
DK0503887T3 (da) Fremme af sårheling med 15-ketoprostaglandinforbindelser
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
SE9100920D0 (sv) New active compounds
FI852806A0 (fi) 2-substituerade -1,3-propylidendifosfonatderivat och deras framstaellning.
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
DK0469782T3 (da) Behandling af katarakt med prostacyclinforbindelser
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.